Toronto, Ontario / TheNewswire / September 26, 2017 – BlueOcean NutraSciences Inc. (TSXV:BOC) ("BlueOcean" or the "Company") is pleased to announce that it has received its first order from its exclusive Canadian distributor, Nutrition Excellence, for its consumer shrimp oil products, Pure Polar® Omega-3 Shrimp Oil, Sport AXTM and Joint AXTM.

 

Nutrition Excellence will distribute the products to retailers across Canada including small and large chain health stores, grocery stores, pharmacies and independents. They will initially target smaller stores as these stores typically buy new products year round. Nutrition Excellence has also been actively presenting the products to a number of larger retailers in preparation for their Q1 2018 planograms and category resets.

The Company is currently producing Canadian compliant inventory for Nutrition Excellence to sell in Canada. This inventory will be available for delivery to Nutrition Excellence and their Canadian customers by mid-October.

 

BlueOcean CEO, Dr. Marvin Heuer commented, “Having finally received our Health Canada NPNs for Sport AXTM and Joint AXTM, we are now able to produce inventory for the Canadian market. Since receiving the Canadian approvals in July, Nutrition Excellence has begun presenting our products to the larger Canadian retailers in preparation for their Q1 2018 planograms and category resets. Initial feedback from these larger retailers has been positive. Once Nutrition Excellence receives their order for Canadian inventory, they can begin selling directly to the smaller Canadian stores who are typically open to adding new products year round.”

 

About BlueOcean

BlueOcean NutraSciences Inc. is a Canadian public listed company (TSXV:BOC) whose mission is to develop effective, innovative and sustainable products from Natural Sources, to improve the lives of its customers. This includes naturally accelerating plant growth. BlueOcean's first specialty ingredient is its patent protected shrimp oil which is the base for its current three consumer brands. Shrimp oil is made from sustainably managed North Atlantic cold water shrimp shells (the by-product of the cooked and peeled shrimp process) which contains phospholipid bound omega-3 fatty acids and over 40 times more natural astaxanthin compared to krill oil ingredients.

Shrimp oil's unique nutritional properties enables the ingredient to make numerous health claims across a wide range of markets, including the $4Bn omega-3 heart health market, the $9Bn joint health market and the $10Bn sports supplement market. BlueOcean markets its shrimp oil ingredient through a number of consumer brands that are formulated to target these specific markets.

BlueOcean currently markets its shrimp oil under three consumer brands: Pure Polar(R) Omega-3 Shrimp Oil, Joint AXTM and Sport AXTM. Products may be purchased online at purepolarlabs.com

Its CO2 gas infusion technology is being commercialized by applying the dissolved CO2 water to plant leaves via foliar spray as a novel means to provide CO2 more efficiently to greenhouse plants. Applying CO2 to plants by foliar spray can potentially save a greenhouse up to 60% of its CO2 costs which are currently being wasted, and accelerate plant growth for higher yields. The technology is targeted at the $340Bn Global Greenhouse Vegetables market, as well as the $14Bn US Indoor grow market and $7Bn US and Canadian Cannabis markets. The Company filed for a USPTO Patent that is the first of its kind for applying CO2 to plants via foliar spray. No other patent has been issued for applying CO2 to plants by foliar spray.

Forward-Looking Statements

This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information, please visit www.blueoceannutra.ca or contact Sam Kanes, VP Strategy and IR at 416-315-7477 or Dil Vashi, VP Operations at 416-859-0909.